| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10549-013-2654-3 |
| P8608 | Fatcat ID | release_jj3nhbmtqjgspbolrqzu3wcupq |
| P698 | PubMed publication ID | 23912960 |
| P5875 | ResearchGate publication ID | 255177505 |
| P50 | author | Sara Gandini | Q51845664 |
| Elisabetta Munzone | Q56850295 | ||
| Aron Goldhirsch | Q87121329 | ||
| Nicole Rotmensz | Q102227952 | ||
| P2093 | author name string | Carlo Cipolla | |
| Marco Colleoni | |||
| Vincenzo De Giorgi | |||
| Giuseppe Viale | |||
| Edoardo Botteri | |||
| Laura Adamoli | |||
| Arnaldo Zanelotti | |||
| Barbara Santillo | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | triple-negative breast cancer | Q7843332 |
| P304 | page(s) | 567-575 | |
| P577 | publication date | 2013-08-03 | |
| P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
| P1476 | title | Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women | |
| P478 | volume | 140 |
| Q35077524 | A nervous tumor microenvironment: the impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic response |
| Q90075385 | Activation of β2-Adrenergic Receptor Promotes Growth and Angiogenesis in Breast Cancer by Down-regulating PPARγ |
| Q50286895 | Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response |
| Q83500366 | Antihypertensive medications are associated with the risk of kidney and bladder cancer: a systematic review and meta-analysis |
| Q36428086 | Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells |
| Q47689970 | Best practice in the administration of analgesia in postoncological surgery |
| Q50535266 | Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice. |
| Q50045986 | Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association. |
| Q27333172 | Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination |
| Q35609448 | Chronic stress, sympathetic activation and skeletal metastasis of breast cancer cells |
| Q35586501 | Impact of beta-blockers on prostate cancer mortality: a meta-analysis of 16,825 patients |
| Q30250324 | Impact of statin use on cancer recurrence and mortality in breast cancer: A systematic review and meta-analysis |
| Q38293740 | Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system. |
| Q33555154 | Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches |
| Q26801748 | Neural Regulation of Pancreatic Cancer: A Novel Target for Intervention |
| Q26746714 | Neural regulation of cancer: from mechanobiology to inflammation |
| Q90602239 | Prometastatic Molecular Profiles in Breast Tumors From Socially Isolated Women |
| Q35858235 | Propranolol Reduces Cancer Risk: A Population-Based Cohort Study |
| Q90402402 | Propranolol and breast cancer-a work in progress |
| Q58761654 | Propranolol for the treatment of vascular sarcomas |
| Q26771704 | Re-Use of Established Drugs for Anti-Metastatic Indications |
| Q98164813 | Repurposing of drugs for triple negative breast cancer: an overview |
| Q37337499 | Role of sympathetic nerves in the establishment of metastatic breast cancer cells in bone |
| Q92138562 | Stress and catecholamines modulate the bone marrow microenvironment to promote tumorigenesis |
| Q99572232 | Stress reduction strategies in breast cancer: review of pharmacologic and non-pharmacologic based strategies |
| Q26795614 | Sympathetic nervous system regulation of the tumour microenvironment |
| Q47863448 | Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy. |
| Q41036251 | The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy |
| Q57168537 | The effects of beta-blocker use on cancer prognosis: a meta-analysis based on 319,006 patients |
| Q38664877 | The potential anticancer effect of beta-blockers and the genetic variations involved in the interindividual difference |
| Q36570909 | The β2-adrenoceptor activates a positive cAMP-calcium feedforward loop to drive breast cancer cell invasion. |
| Q36029475 | Use of Antihypertensive Medications Not Associated with Risk of Contralateral Breast Cancer among Women Diagnosed with Estrogen Receptor-Positive Invasive Breast Cancer |
| Q38625054 | Use of antihypertensive medications and risk of adverse breast cancer outcomes in a SEER-Medicare population |
| Q38750495 | Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysis |
| Q35527903 | α2-Adrenergic blockade mimics the enhancing effect of chronic stress on breast cancer progression. |
| Q36213505 | β-Adrenergic receptors suppress Rap1B prenylation and promote the metastatic phenotype in breast cancer cells |
| Q36321486 | β2-adrenoceptor signaling regulates invadopodia formation to enhance tumor cell invasion. |
Search more.